Practical Recommendations of Scientific Society for the Study of Human Microbiome and Russian Gastroenterological Association (RGA) for Probiotics in Treatment and Prevention of Gastroenterological Diseases in Adults

Author:

Ivashkin V. T.1ORCID,Mayev I. V.2ORCID,Abdulganieva D. I.3ORCID,Alekseenko S. A.4ORCID,Ivashkina N. Yu.2ORCID,Korochanskaya N. V.5ORCID,Mammaev S. N.6ORCID,Poluektova E. A.1ORCID,Trukhmanov A. S.1ORCID,Uspensky Yu. P.7ORCID,Tsukanov V. V.8ORCID,Shifrin O. S.1ORCID,Zolnikova O. Yu.1ORCID,Ivashkin K. V.1ORCID,Lapina T. L.1ORCID,Maslennikov R. V.1ORCID,Ulyanin A. I.1ORCID

Affiliation:

1. I.M. Sechenov First Moscow State Medical University (Sechenov University)

2. A.I. Yevdokimov Moscow State University of Medicine and Dentistry

3. Kazan State Medical University

4. Far Eastern State Medical University

5. Kuban State Medical University

6. Dagestan State Medical University

7. St. Petersburg State Pediatric Medical University

8. Federal Research Centre “Krasnoyarsk Scientific Centre of the Siberian Branch of the Russian Academy of Sciences” — Scientific Research Institute of Medical Problems of the North

Abstract

Aim. To provide practical recommendations on the use of probiotics for the treatment and prevention of gastroenterological diseases in adults.General provisions. Probiotics are living microorganisms that benefit the health of the host when administered in adequate amounts. The main functions of probiotics include the support for colonisation resistance, the metabolism of food substrates and utilisation of end metabolites, the production of substrates necessary for the macro-organism, as well as the regulation of local and adaptive immune responses. Probiotics can be registered in the Russian Federation as biologically active food additives (BAFA) or as pharmaceutical products (drugs) in accordance with the microbiological standards and legislative requirements of the Russian Federation. The probiotics registered in the Russian Federation as BAFA for adults include bacteria of the Lactobacillus, Bifidobacterium, Enterococcus, Pediococcus, Lactococcus, Streptococcus, Bacillus, and Escherichia genera, and fungi of the Saccharomyces genus; probiotics registered as drugs — bacteria of Lactobid, Lactobacid, Escherichia and Enterococcus genera and fungi of the Saccharomyces genus. Some probiotics registered in the Russian Federation include probiotic strains that have proved to be effective for the prevention and treatment of antibiotic-associated diarrhea, the prevention of C. difficile-associated disease, the eradication of H. pylori infection, as well as for the treatment of irritable bowel syndrome and functional constipation.Conclusions. The clinical efficacy of probiotics depends on the probiotic strains included in their composition and is confirmed by a comparative analysis of the results of appropriate clinical studies. Not all probiotics registered in the Russian Federation as BAFA or drugs contain bacterial or fungal strains; as a result, the expected clinical effect may not be achieved.

Publisher

Russian Gastroenterolgocial Society

Cited by 16 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3